<DOC>
	<DOCNO>NCT01703026</DOCNO>
	<brief_summary>Contrast enhance EUS sonographic contrast agent DEFINITY™ potential detect pancreatic cancer earlier stage , improve current method T stag assessment surgical resectability also distinguish benign malignant pancreatic mass . All translate good clinical outcome , also avoid unnecessary surgery situation unresectable cancer .</brief_summary>
	<brief_title>Contrast Enhanced EUS Evaluation Pancreatic Cancer Pancreatic Masses</brief_title>
	<detailed_description />
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<criteria>Consecutive patient 1year period refer EUS examination due suspect pancreatic lesion enrol . Age 21 year . Ability provide inform consent Patients clinical condition preclude use DEFINITY™ exclude . These condition : Righttoleft , bidirectional , transient righttoleft cardiac shunt ; Worsening clinically unstable congestive heart failure ; Acute myocardial infarction acute coronary syndrome ; Serious ventricular arrhythmias high risk arrhythmia due prolongation QT interval ; Respiratory failure ; Severe emphysema , pulmonary embolus condition cause pulmonary hypertension due compromise pulmonary arterial vasculature ; Hypersensitivity DEFINITY™ component .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2012</verification_date>
</DOC>